FREE Account Opening + No Clearing Fees
Loading...

ANG Lifesciences IPO vs Nouritrans Exim IPO

Comparision between ANG Lifesciences IPO and Nouritrans Exim IPO.

IPO Details

ANG Lifesciences IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Nouritrans Exim IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  ANG Lifesciences IPO Nouritrans Exim IPO
Logo ANG Lifesciences IPO Logo Nouritrans Exim IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME BSE SME
Lead Managers Oneview Corporate Advisors Pvt. Ltd. First Overseas Capital Limited
Registrar Bigshare Services Pvt Ltd Kfin Technologies Limited
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of ANG Lifesciences IPO is up to ₹12.01 Cr whereas the issue size of the Nouritrans Exim IPO is up to ₹6.12 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Nouritrans Exim IPO is ₹30.00 per share.

  ANG Lifesciences IPO Nouritrans Exim IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹80.00 per share ₹30.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1600 shares 4000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 15,00,800 shares 20,40,000 shares
Issue Size Total (Amount) up to ₹12.01 Cr up to ₹6.12 Cr

IPO Timetable

ANG Lifesciences IPO opens on Aug 29, 2017, while Nouritrans Exim IPO opens on Sep 04, 2017. The closing date of ANG Lifesciences IPO and Nouritrans Exim IPO is Aug 31, 2017, and Sep 07, 2017, respectively.

  ANG Lifesciences IPO Nouritrans Exim IPO
Anchor Bid Date
Issue Open Aug 29, 2017 Sep 04, 2017
Issue Close Aug 31, 2017 Sep 07, 2017
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

ANG Lifesciences IPO P/E ratio is , as compared to Nouritrans Exim IPO P/E ratio of .

  ANG Lifesciences IPO Nouritrans Exim IPO
Financial
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the ANG Lifesciences IPO retail investors (RII) are offered 7,12,000 shares while in Nouritrans Exim IPO retail investors are offered 7,12,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in ANG Lifesciences IPO and 0 shares in Nouritrans Exim IPO.

  ANG Lifesciences IPO Nouritrans Exim IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 0 shares 0 shares
NII 7,12,000 shares 10,20,000 shares
RII 7,12,000 shares 10,20,000 shares
Employee
Others
Total 14,24,000 shares 20,40,000 shares

Bids Received (Subscription)

ANG Lifesciences IPO subscribed in total, whereas Nouritrans Exim IPO subscribed .

  ANG Lifesciences IPO Nouritrans Exim IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)

Comments

Add a public comment...